Apr 29 |
Down -6.19% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround
|
Apr 26 |
Bristol, Sanofi, Takeda gain positive CHMP recommendations
|
Apr 26 |
Down -5.9% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround
|
Apr 26 |
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
|
Apr 26 |
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
|
Apr 25 |
Takeda said to have left industry trade group BIO
|
Apr 25 |
All You Need to Know About Takeda Pharmaceutical Co. (TAK) Rating Upgrade to Strong Buy
|
Apr 25 |
TAK or CTLT: Which Is the Better Value Stock Right Now?
|
Apr 25 |
20 Fastest Growing Health Tech Companies in the World
|
Apr 25 |
New Strong Buy Stocks for April 25th
|